During the past decade, Seattle Cancer Care Alliance at Northwest Hospital conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 11 clinical trials were completed, i.e. on average, 57.9% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 10 clinical trials were completed. i.e. 250% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Seattle Cancer Care Alliance at Northwest Hospital" #1 sponsor was "SWOG Cancer Research Network" with 13 trials, followed by "National Cancer Institute (NCI)" with 8 trials sponsored, "Alliance for Clinical Trials in Oncology" with 4 trials sponsored, "NRG Oncology" with 2 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Seattle Cancer Care Alliance at Northwest Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 21 trials as a collaborator, "Canadian Cancer Trials Group" with 3 trials as a collaborator, "NRG Oncology" with 2 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Radiation Therapy Oncology Group" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Seattle Cancer Care Alliance at Northwest Hospital" are "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Recurrent Lung Non-Small Cell Carcinoma" (3 trials), "Chronic Lymphocytic Leukemia" (2 trials) and "Small Lymphocytic Lymphoma" (2 trials). Many other conditions were trialed in "Seattle Cancer Care Alliance at Northwest Hospital" in a lesser frequency.

Most popular intervention types in "Seattle Cancer Care Alliance at Northwest Hospital" are "Drug" (25 trials), "Other" (21 trials), "Biological" (12 trials), "Procedure" (7 trials) and "Radiation" (7 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (10 trials), "Quality-of-Life Assessment" (8 trials), "Docetaxel" (6 trials), "Questionnaire Administration" (6 trials) and "Biospecimen Collection" (4 trials). Other intervention names were less common.

The vast majority of trials in "Seattle Cancer Care Alliance at Northwest Hospital" are 27 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Seattle Cancer Care Alliance at Northwest Hospital". undefined are not yet recruiting, 8 are recruiting, 13 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Seattle Cancer Care Alliance at Northwest Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Seattle Cancer Care Alliance at Northwest Hospital, 0 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".